The goal of this webinar series from the CTN Western States Node and the Northwest and Pacific Southwest ATTCs is to help scholars and clinicians in the addiction field stay abreast of cutting edge science.
In this session, John Kelly, PhD, ABPP of Harvard University will discuss the fundamental causes of stigma and discrimination in relation to substance use disorder, review some of the paradoxical findings from the latest stigma research, and suggest how stigma and discrimination might be more systematically addressed to enhance the clinical care and outcomes of individuals suffering from substance use disorder.
- Identify two (2) major factors which underlie and contribute to addiction stigma.
- Explain three (3) effective strategies for addressing stigma.
- Determine optimal terminology to reduce stigma in at least two (2) clinical and policy communication areas.
1.5 CME or CE credits available. AMA PRA Category 1 Credits(TM); PSY (APA); RN (CA BRN); LMFT, LCSW, LPCC, LEP (CAMFT); RADT I/II, CADC-CAS, CADC I/II, CADC-CS, LAADC (CCAPP); CATC (ACCBC/CAADE); CAODC (CADTP).
For details on these credits, please see our flyer.